• $1,331.00
    Market Cap
  • -75.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
12,500
N/A
Cost of Revenue
546,000
N/A
N/A
N/A
N/A
N/A
Gross Profit
-546,000
N/A
0
-100.00%
12,500
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-417,450
-66.18%
-1.2M
-31.17%
-1.8M
N/A
Depreciation and Amortization Expense
1.0M
-1.67%
1.0M
+153.76%
409,368
N/A
Total Operating Expenses
2.0M
-30.01%
2.9M
-0.50%
2.9M
N/A
Operating Profit
-2.0M
-30.01%
-2.9M
-0.06%
-2.9M
N/A
Interest Income
1,335
+121.03%
604
+62.37%
372
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
1,335
+121.03%
604
+62.37%
372
N/A
Total Nonoperating Income and Expense
79,335
-5.55%
83,999
-53.48%
180,559
N/A
Income before Taxes
-1.9M
-30.74%
-2.8M
+3.51%
-2.7M
N/A
Income Taxes
N/A
N/A
-987,353
0.00%
-987,353
N/A
Extraordinary Items
N/A
N/A
0
N/A
N/A
N/A
Net Income
-1.9M
-30.74%
-2.8M
+63.21%
-1.7M
N/A
Net Income from Continuing Operations Applicable to Common
-2.2M
-26.99%
-3.1M
+54.17%
-2.0M
N/A
Basic EPS and Net Income
-0.35
-32.69%
-0.52
+52.94%
-0.34
N/A
Diluted EPS and Net Income
-0.35
-32.69%
-0.52
+52.94%
-0.34
N/A
Basic Weighted Average Shares
6.5M
+9.81%
5.9M
0.00%
5.9M
N/A
Diluted Weighted Average Shares
6.5M
+9.81%
5.9M
0.00%
5.9M
N/A
Balance Sheet
Cash and Cash Equivalents
577,066
+169.65%
214,009
-0.85%
215,836
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
577,066
+169.65%
214,009
-0.85%
215,836
N/A
Total Current Assets
698,913
+173.23%
255,801
-7.85%
277,593
N/A
Accumulated Depreciation
499,709
+3.04%
484,967
+7.08%
452,902
N/A
Property and Plant and Equipment and Net
3,956
-78.84%
18,698
-63.17%
50,763
N/A
Total Long-Term Assets
1.7M
-38.17%
2.7M
-27.96%
3.7M
N/A
Total Assets
2.4M
-19.73%
2.9M
-26.56%
4.0M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
178,240
+844.77%
18,866
+496.27%
3,164
N/A
Total Long-Term Debt
3.7M
0.00%
3.7M
+66.70%
2.2M
N/A
Total Long-Term Liabilities
3.7M
0.00%
3.7M
+66.70%
2.2M
N/A
Total Liabilities
3.9M
+4.24%
3.8M
+67.30%
2.2M
N/A
Retained Earnings
-19.8M
+10.82%
-17.9M
+18.52%
-15.1M
N/A
Total Stockholders Equity
-5.6M
+27.08%
-4.4M
+140.98%
-1.8M
N/A
Total Shares Outstanding
6.7M
+13.15%
5.9M
0.00%
5.9M
N/A
Cash Flow
Cash from Operating Activities
-640,947
-59.51%
-1.6M
-31.09%
-2.3M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
147,613
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.0M
-36.51%
1.6M
-31.84%
2.3M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-23,038.36%
N/A
Return on Assets
-73.21%
-9.27%
-80.69%
+94.10%
-41.57%
N/A
Return on Equity
38.73%
-56.85%
89.75%
-43.39%
158.54%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
-89.81%
N/A
Current Ratio
3.92
-71.08%
13.56
-84.55%
87.73
N/A
Cash Ratio
3.24
-71.46%
11.34
-83.37%
68.22
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow